UnitedHealth Group (NYSE:UNH) had its price objective upped by UBS Group from $257.00 to $279.00 in a research report report published on Wednesday morning, BenzingaRatingsTable reports. UBS Group currently has a neutral rating on the healthcare conglomerate’s stock.
UNH has been the topic of a number of other research reports. Cantor Fitzgerald lifted their target price on UnitedHealth Group from $310.00 to $315.00 and gave the company a buy rating in a research report on Wednesday. Citigroup lowered their target price on shares of UnitedHealth Group from $299.00 to $286.00 and set a buy rating for the company in a research note on Wednesday, October 16th. SunTrust Banks reaffirmed a buy rating and set a $335.00 target price (up previously from $310.00) on shares of UnitedHealth Group in a research note on Monday, November 18th. Morgan Stanley reiterated a buy rating and set a $312.00 price target (up from $294.00) on shares of UnitedHealth Group in a research report on Friday, November 22nd. Finally, Wells Fargo & Co boosted their price target on shares of UnitedHealth Group from $288.00 to $318.00 and gave the company an in-line rating in a research note on Wednesday. Six equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. UnitedHealth Group presently has a consensus rating of Buy and an average price target of $299.35.
Shares of UNH stock traded up $1.03 during trading hours on Wednesday, reaching $280.35. The company had a trading volume of 1,151,168 shares, compared to its average volume of 4,470,949. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.70 and a current ratio of 0.70. The stock has a fifty day moving average of $260.30 and a 200-day moving average of $245.75. The company has a market capitalization of $264.70 billion, a price-to-earnings ratio of 21.77, a PEG ratio of 1.48 and a beta of 0.64. UnitedHealth Group has a 12-month low of $208.07 and a 12-month high of $283.00.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be given a dividend of $1.08 per share. This represents a $4.32 dividend on an annualized basis and a dividend yield of 1.54%. The ex-dividend date of this dividend is Friday, December 6th. UnitedHealth Group’s dividend payout ratio is presently 33.54%.
In other news, EVP D Ellen Wilson sold 7,400 shares of the company’s stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $272.77, for a total transaction of $2,018,498.00. Also, CAO Thomas E. Roos sold 1,177 shares of the stock in a transaction dated Thursday, November 7th. The stock was sold at an average price of $255.04, for a total transaction of $300,182.08. Following the transaction, the chief accounting officer now owns 21,687 shares in the company, valued at $5,531,052.48. The disclosure for this sale can be found here. Over the last three months, insiders have sold 38,577 shares of company stock valued at $9,398,080. Corporate insiders own 0.82% of the company’s stock.
Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Eagle Capital Management LLC lifted its stake in UnitedHealth Group by 0.9% in the 2nd quarter. Eagle Capital Management LLC now owns 16,213 shares of the healthcare conglomerate’s stock valued at $3,956,000 after purchasing an additional 147 shares during the last quarter. Texas Yale Capital Corp. bought a new position in UnitedHealth Group during the second quarter worth $383,000. Edge Capital Group LLC acquired a new position in shares of UnitedHealth Group in the second quarter valued at $271,000. Wambolt & Associates LLC raised its position in shares of UnitedHealth Group by 14.9% in the second quarter. Wambolt & Associates LLC now owns 1,523 shares of the healthcare conglomerate’s stock valued at $372,000 after purchasing an additional 198 shares during the period. Finally, KMG Fiduciary Partners LLC raised its position in shares of UnitedHealth Group by 17.8% in the second quarter. KMG Fiduciary Partners LLC now owns 5,033 shares of the healthcare conglomerate’s stock valued at $1,228,000 after purchasing an additional 760 shares during the period. 85.50% of the stock is currently owned by institutional investors and hedge funds.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Further Reading: What is the S&P/TSX Index?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.